Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine
DeviceTalks Podcast Network
Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Jul 23 2021 | 00:42:16

/
Episode • July 23, 2021 • 00:42:16

Hosted By

Kayleen Brown Tom Salemi

Show Notes

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Previous Episode

Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

Next Episode

What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Other Episodes

February 10, 2023

Needham’s Matson, Saxon break down the Abbott-CSI and Globus-Nuvasive deals. Is more M&A on the way?

The weekend ended with a bang as Abbott and Globus Medical both announced significant deals. Abbott picked up publicly traded Cardiovascular Solutions for $890...

Play

00:48:45

July 23, 2024

Abbott’s Fishler on Dual Chamber Leadless Pacemaker from “submarine” tests to FDA approval

In this episode of AbbottTalks, Matthew Fishler, PhD, Chief Engineer & Senior Director, Product Development, Cardiac Rhythm Management at Abbott Cardiovascular, shares his experience...

Play

00:41:41

October 23, 2020

Philips' Imaged Guided leader Landon shares global giant's plans for minimally invasive devices

In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips...

Play

00:36:34